Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Christopher T. Harvey"'
Autor:
Hao Geng, Hyun-Kyung Ko, Janet Pittsenbarger, Christopher T. Harvey, Changhui Xue, Qiong Liu, Sadie Wiens, Sushant K. Kachhap, Tomasz M. Beer, David Z. Qian
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Hypoxia is a universal pathological feature of solid tumors. Hypoxic tumor cells acquire metastatic and lethal phenotypes primarily through the activities of hypoxia-inducible factor 1 alpha (HIF1α). Therefore, HIF1α is considered as a promising th
Externí odkaz:
https://doaj.org/article/3a9e4a94373f48bca52a168e994e4acf
Autor:
David Z. Qian, Tomasz M. Beer, Peter S. Nelson, Mark Garzotto, Anne Myrthue, Marie C. Lafortune, Christopher T. Harvey, Chung-Ying Huang, Janet Pittsenbarger, Brooks L. Rademacher, Hao Geng
Supplementary Figures 1-4 from ID1 Enhances Docetaxel Cytotoxicity in Prostate Cancer Cells through Inhibition of p21
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b7e768a1e8c346d4c9fe37aefb110bf
https://doi.org/10.1158/0008-5472.22386513.v1
https://doi.org/10.1158/0008-5472.22386513.v1
Autor:
David Z. Qian, Tomasz M. Beer, Peter S. Nelson, Mark Garzotto, Anne Myrthue, Marie C. Lafortune, Christopher T. Harvey, Chung-Ying Huang, Janet Pittsenbarger, Brooks L. Rademacher, Hao Geng
Supplementary Figure Legends 1-12 from ID1 Enhances Docetaxel Cytotoxicity in Prostate Cancer Cells through Inhibition of p21
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::865667f0fff0401756e87366d48bdada
https://doi.org/10.1158/0008-5472.22386516.v1
https://doi.org/10.1158/0008-5472.22386516.v1
Autor:
David Z. Qian, Tomasz M. Beer, Peter S. Nelson, Mark Garzotto, Anne Myrthue, Marie C. Lafortune, Christopher T. Harvey, Chung-Ying Huang, Janet Pittsenbarger, Brooks L. Rademacher, Hao Geng
Supplementary Figures 7-9 from ID1 Enhances Docetaxel Cytotoxicity in Prostate Cancer Cells through Inhibition of p21
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e4094b24834a479026689cd185c33b2
https://doi.org/10.1158/0008-5472.22386501.v1
https://doi.org/10.1158/0008-5472.22386501.v1
Autor:
David Z. Qian, Tomasz M. Beer, Peter S. Nelson, Mark Garzotto, Anne Myrthue, Marie C. Lafortune, Christopher T. Harvey, Chung-Ying Huang, Janet Pittsenbarger, Brooks L. Rademacher, Hao Geng
Supplementary Figure 12 from ID1 Enhances Docetaxel Cytotoxicity in Prostate Cancer Cells through Inhibition of p21
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::462e40f24657ab15cad147c7fbc328aa
https://doi.org/10.1158/0008-5472.22386519
https://doi.org/10.1158/0008-5472.22386519
Autor:
David Z. Qian, Tomasz M. Beer, Peter S. Nelson, Mark Garzotto, Anne Myrthue, Marie C. Lafortune, Christopher T. Harvey, Chung-Ying Huang, Janet Pittsenbarger, Brooks L. Rademacher, Hao Geng
Supplementary Figures 5-6 from ID1 Enhances Docetaxel Cytotoxicity in Prostate Cancer Cells through Inhibition of p21
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4462319f0aeb3ad6556165bc6adb5d4
https://doi.org/10.1158/0008-5472.22386507
https://doi.org/10.1158/0008-5472.22386507
Autor:
Hyun-Kyung Ko, David Z. Qian, Janét Pittsenbarger, Christopher T. Harvey, Tomasz M. Beer, Sushant Kachhap, Sadie Wiens, Changhui Xue, Qiong Liu, Hao Geng
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Frontiers in Cell and Developmental Biology
Frontiers in Cell and Developmental Biology
Hypoxia is a universal pathological feature of solid tumors. Hypoxic tumor cells acquire metastatic and lethal phenotypes primarily through the activities of hypoxia-inducible factor 1 alpha (HIF1α). Therefore, HIF1α is considered as a promising th
Autor:
Christopher T. Harvey, Tomasz M. Beer, Hao Geng, Changhui Xue, David Z. Qian, Qiong Liu, Vivian Chen
BACKGROUND Resistance to chemotherapy represents a significant obstacle in prostate cancer therapeutics. Novel mechanistic understandings in cancer cell chemotherapeutic sensitivity and resistance can optimize treatment and improve patient outcome. M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4dbe14d94944d8d854524b6afa5ec090
https://europepmc.org/articles/PMC3888097/
https://europepmc.org/articles/PMC3888097/
Autor:
Janét Pittsenbarger, Brooks L. S. Rademacher, Marie C. Lafortune, Anne Myrthue, Chung Ying Huang, Mark Garzotto, Hao Geng, Tomasz M. Beer, Peter S. Nelson, Christopher T. Harvey, David Z. Qian
Publikováno v:
Cancer research. 70(8)
To identify potential mechanisms underlying prostate cancer chemotherapy response and resistance, we compared the gene expression profiles in high-risk human prostate cancer specimens before and after neoadjuvant chemotherapy and radical prostatectom